Cargando…

The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation

BACKGROUND: Substance P (SP) is a pleiotropic cytokine/neuropeptide that enhances breast cancer (BC) aggressiveness by transactivating tyrosine kinase receptors like EGFR and HER2. We previously showed that SP and its cognate receptor NK-1 (SP/NK1-R) signaling modulates the basal phosphorylation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Recio, Susana, Pastor-Arroyo, Eva M., Marín-Aguilera, Mercedes, Almendro, Vanessa, Gascón, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482606/ https://www.ncbi.nlm.nih.gov/pubmed/26114632 http://dx.doi.org/10.1371/journal.pone.0129661

Ejemplares similares

Monocyte Transmodulation: The Next Novel Therapeutic Approach in Overcoming Ischemic Stroke?
por: Park, Joohyun, et al.
Publicado: (2020)

Corrigendum: Monocyte Transmodulation: The Next Novel Therapeutic Approach in Overcoming Ischemic Stroke?
por: Park, Joohyun, et al.
Publicado: (2020)

Tumor promoting effects of CD95 signaling in chemoresistant cells
por: Ametller, Elisabet, et al.
Publicado: (2010)

The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin
por: Almendro, Vanessa, et al.
Publicado: (2009)

Progesterone and its metabolite allopregnanolone promote invasion of human glioblastoma cells through metalloproteinase‑9 and cSrc kinase
por: Bello-Alvarez, Claudia, et al.
Publicado: (2023)

Antagonistic control of tumor necrosis factor receptors by protein kinases A and C. Enhancement of TNF receptor synthesis by protein kinase A and transmodulation of receptors by protein kinase C
Publicado: (1989)

Biological and Pharmacological Aspects of the NK1-Receptor
por: Garcia-Recio, Susana, et al.
Publicado: (2015)

Comparison of methods for the isolation of human breast epithelial and myoepithelial cells
por: Zubeldia-Plazaola, Arantzazu, et al.
Publicado: (2015)

c-Src/Cav1-dependent activation of the EGFR by Dsg2
por: Overmiller, Andrew M., et al.
Publicado: (2016)

c-Src Increases the Sensitivity to TKIs in the EGFR-Mutant Lung Adenocarcinoma
por: Min, Weili, et al.
Publicado: (2021)

Thrombin Promotes Matrix Metalloproteinase-13 Expression through the PKCδ/c-Src/EGFR/PI3K/Akt/AP-1 Signaling Pathway in Human Chondrocytes
por: Huang, Chun-Yin, et al.
Publicado: (2013)

Novel agents that downregulate EGFR, HER2, and HER3 in parallel
por: Ferreira, Renan Barroso, et al.
Publicado: (2015)

Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer
por: Marín-Aguilera, Mercedes, et al.
Publicado: (2015)

Correction: Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer
por: Marín-Aguilera, Mercedes, et al.
Publicado: (2017)

Gallic acid suppresses colon cancer proliferation by inhibiting SRC and EGFR phosphorylation
por: Lin, Xiaoming, et al.
Publicado: (2021)

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
por: Sassen, Andrea, et al.
Publicado: (2008)

Model-Based Analysis of HER Activation in Cells Co-Expressing EGFR, HER2 and HER3
por: Shankaran, Harish, et al.
Publicado: (2013)

Structure and dynamics of the EGFR/HER2 heterodimer
por: Bai, Xue, et al.
Publicado: (2023)

Clinical implications of the coexpression of SRC1 and NANOG in HER-2-overexpressing breast cancers
por: Jin, Chengyan, et al.
Publicado: (2016)

mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells
por: Colella, Barbara, et al.
Publicado: (2020)

The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling
por: Asbagh, Layka Abbasi, et al.
Publicado: (2014)

The inhibition of Src kinase suppresses the production of matrix metalloproteinases in from synovial fibroblasts and inhibits MAPK and STATs pathways
por: YALÇIN KEHRİBAR, Demet, et al.
Publicado: (2021)

Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma
por: Peiró, G, et al.
Publicado: (2014)

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2
por: Kim, Hwang-Phill, et al.
Publicado: (2009)

Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers
por: Khelwatty, Said A, et al.
Publicado: (2015)

Carvacrol: An In Silico Approach of a Candidate Drug on HER2, PI3Kα, mTOR, hER-α, PR, and EGFR Receptors in the Breast Cancer
por: Herrera-Calderon, Oscar, et al.
Publicado: (2020)

Matrix Metalloproteinase-12 Is Required for Granuloma Progression
por: Mohan, Arjun, et al.
Publicado: (2020)

An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer
por: Tai, Yu-Ling, et al.
Publicado: (2015)

EGFR–c-Src-Mediated HDAC3 Phosphorylation Exacerbates Invasion of Breast Cancer Cells
por: Kwak, Sung-Min, et al.
Publicado: (2019)

Asporin enhances colorectal cancer metastasis through activating the EGFR/Src/cortactin signaling pathway
por: Wu, Huo, et al.
Publicado: (2016)

c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?
por: Belli, Stefania, et al.
Publicado: (2020)

EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
por: Fang, Runping, et al.
Publicado: (2021)

C-terminal Src kinase (Csk) regulates the tricellular junction protein Gliotactin independent of Src
por: Samarasekera, G. D. N. Gayathri, et al.
Publicado: (2018)

Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors
por: Rye, Inga H., et al.
Publicado: (2018)

Differential expression of neurogenes among breast cancer subtypes identifies high risk patients
por: Fernández-Nogueira, Patricia, et al.
Publicado: (2015)

Diverse Requirements for Src-Family Tyrosine Kinases Distinguish Chlamydial Species
por: Mital, Jeffrey, et al.
Publicado: (2011)

N1-Src Kinase Is Required for Primary Neurogenesis in Xenopus tropicalis
por: Lewis, Philip A., et al.
Publicado: (2017)

c-Src activity is differentially required by cancer cell motility modes
por: Logue, Jeremy S., et al.
Publicado: (2018)

PGE(2)/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells
por: Bazzani, Lorenzo, et al.
Publicado: (2017)

Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression
por: Pan, Zhenzhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h34f4f9do89p7rqqpkorkovvil